Indication
RRMM
1 clinical trial
2 products
Clinical trial
A Randomized, Two-period, Cross-over, Phase 2 Study, Comparing Pharmacokinetics, and Assessing Safety and Tolerability of Peripheral and Central i.v. Administration of Melphalan Flufenamide (Melflufen) in RRMM PatientsStatus: Terminated, Estimated PCD: 2021-06-02
Product
DexamethasoneProduct
Melphalan